Western Family Tartar Control

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available text.

Uses and Indications

This drug is indicated for the protection against cavities.

There are no teratogenic effects associated with this drug, nor are there any nonteratogenic effects mentioned.

Dosage and Administration

Adults and children aged 2 years and older are advised to brush their teeth thoroughly, preferably after each meal, or at least twice daily, or as directed by a dentist. It is important to ensure that the product is not swallowed during the brushing process.

For children under 6 years of age, a pea-sized amount of the product should be used to minimize the risk of swallowing. Caregivers should supervise the brushing process until proper oral hygiene habits are established.

For children under 2 years of age, it is recommended to consult a dentist or physician for guidance on appropriate use.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

As with all fluoride toothpastes, it is imperative to keep this product out of the reach of children under 6 years of age. In the event of accidental ingestion of an amount greater than that typically used for brushing, immediate professional assistance should be sought, or the individual should contact a Poison Control Center without delay.

Healthcare professionals should remain vigilant regarding the potential risks associated with fluoride toothpaste, particularly in pediatric populations. The importance of educating caregivers about the appropriate use and storage of fluoride products cannot be overstated, as this is crucial for preventing accidental ingestion and ensuring the safety of young children.

Side Effects

Patients should be aware of the potential risks associated with the use of fluoride toothpaste. As with all fluoride-containing products, it is crucial to keep the toothpaste out of reach of children under 6 years of age. Accidental ingestion of amounts greater than what is typically used for brushing may lead to adverse effects. In such cases, it is recommended that individuals seek professional medical assistance or contact a Poison Control Center immediately.

This precaution is particularly important to prevent serious health consequences that may arise from excessive fluoride exposure in young children.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Western Family Tartar Control (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored when using fluoride toothpaste. It is recommended that children under 6 years of age be kept out of reach to prevent accidental ingestion. For children aged 2 years and older, it is advised to brush teeth thoroughly, preferably after each meal or at least twice daily, while ensuring that they do not swallow the toothpaste. A pea-sized amount should be used for children under 6 years to minimize swallowing, and adult supervision is necessary until proper brushing habits are established.

For infants and children under 2 years, consultation with a dentist or physician is recommended prior to use. In the event of accidental ingestion of more than the amount used for brushing, professional help should be sought immediately, or a Poison Control Center should be contacted.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of Western Family Tartar Control Sodium Fluoride Paste, Dentifrice during pregnancy. As such, safety concerns, dosage modifications, or special precautions for pregnant patients have not been established. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the benefits against any potential risks when recommending this product during pregnancy.

Lactation

There is no specific information regarding the use of Western Family Tartar Control Sodium Fluoride Paste, Dentifrice in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider this lack of data when advising lactating mothers on the use of this product.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative that healthcare professionals take immediate action. If a patient accidentally ingests more than the recommended amount used for brushing, it is crucial to seek professional assistance without delay.

Healthcare providers should advise the patient or caregiver to contact a Poison Control Center immediately for guidance on the appropriate steps to take. Prompt intervention is essential to mitigate potential adverse effects associated with overdosage.

Monitoring for symptoms related to overdosage is also important, although specific symptoms are not detailed in the provided information. Therefore, healthcare professionals should remain vigilant and prepared to manage any complications that may arise from excessive ingestion.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children to prevent accidental ingestion or misuse. It is important for patients to understand the potential risks associated with improper access to the medication by young children. Providers should emphasize the necessity of storing the medication in a secure location, away from children's sight and reach, to ensure safety.

Storage and Handling

The product is supplied in a configuration suitable for consumer use. It should be stored at room temperature to maintain its efficacy. It is essential to keep the product out of reach of children under 6 years of age to ensure safety. Users are advised not to swallow the toothpaste. If any specific instructions regarding disposal after opening are provided, the product should be discarded accordingly.

Additional Clinical Information

The product is administered via the dental route. Clinicians should advise patients to keep the product out of reach of children under 6 years of age. In the event of accidental ingestion of more than the amount used for brushing, patients should seek professional help or contact a Poison Control Center immediately. To reduce the risk of swallowing, it is recommended to use a pea-sized amount and supervise brushing until proper habits are established. For children under 2 years, consultation with a dentist or physician is advised.

Drug Information (PDF)

This file contains official product information for Western Family Tartar Control, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)